Edwards Lifesciences Raises 2025 Sales Outlook Amid Strong Segment Performance

Published 1 hours agoEW

Edwards Lifesciences Raises 2025 Sales Outlook Amid Strong Segment Performance

Edwards Lifesciences has revised its 2025 sales guidance upward to a range of $5.7 billion to $6.1 billion, sustaining an 8–10% constant currency growth projection. The increase reflects a strong performance across its business segments, particularly emphasizing its commitment to maintain competitive leadership and stable pricing in the market.

The company's Transcatheter Mitral and Tricuspid Therapies (TMTT) segment has shown significant growth, prompting a sales guidance increase to $530–550 million for 2025, up from the previous $500–530 million projection. The Transcatheter Aortic Valve Replacement (TAVR) sales continue to be a major revenue contributor, hitting $1.04 billion in Q4 2024, representing a 6% year-over-year increase and accounting for $4.1 billion in annual sales.

Edwards Lifesciences' strategic focus is on segments like Structural Heart Failure and Aortic Regurgitation, identified as key growth areas. Supporting this strategy, the company reported 6.2% sales growth in Q1 2025, totaling $1.41 billion, with TAVR sales up by 3.8% and TMTT surging by 58% to $115 million. Adjusted EPS for 2025 remains forecasted at $2.40–$2.50, with Q1 adjusted EPS at $0.64. Regulatory advancements include SAPIEN M3 CE Mark approval and expanded U.S. coverage for EVOQUE tricuspid valve replacement, underscoring Edwards' ongoing efforts in innovation and market expansion.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Boeing Faces Turmoil as Trade Tensions Disrupt China Deliveries

Boeing Faces Turmoil as Trade Tensions Disrupt China Deliveries

28 minutes agoBA

Boeing is grappling with significant disruptions due to an escalating trade conflict with China. Chinese airlines have rejected accepting new deliveries of Boeing aircraft, most notably a Boeing 737 Max8 that was originally intended for Xiamen Airlines but returned to the U.S. as a result of the ongoing trade dispute. According to Insider Monkey, the U.S. has levied tariffs as high as 145% on certain Chinese imports, while China has retaliated with tariffs of 125% on U.S. goods, including American aircraft. This trade gridlock has cast uncertainty on Boeing's plans to deliver around 50 aircraft to China by 2025, putting these orders in jeopardy. Despite the turmoil, Boeing reported an 18% revenue increase in the first quarter of 2025, reflecting the complexity of its current market situation. In response to these challenges, Boeing's CEO Kelly Ortberg has announced the company's strategy to remarket unsold jets to other carriers. This move aims to mitigate potential impacts from suspended Chinese orders. Meanwhile, Boeing continues to ramp up production of the MAX aircraft, suggesting a drive to maintain supply chain momentum in the face of international trade volatility.

Impinj Projects Q2 2025 Revenue Growth with Strategic Shifts

Impinj Projects Q2 2025 Revenue Growth with Strategic Shifts

43 minutes agoPI

Impinj has set a revenue expectation for the second quarter of 2025 between $91 million and $96 million. This anticipated growth reflects the company's strategic adjustments aimed at enhancing its market positioning. As reported by Insider Monkey, these adjustments involve extending technology leadership and accelerating platform adoption. Despite a projected decrease in GAAP net income to a range of $5.6 million to $8.1 million from $10.0 million in the previous year, Impinj demonstrates a focus on long-term strategies. The company's ongoing investments in research and development, along with inventory management and responses to geopolitical changes, are influential forces behind these figures. Impinj remains committed to exploring emerging opportunities within the RFID industry by expanding enterprise solutions and entering new geographic markets. The company’s strong performance in the first quarter of 2025, where revenue and profitability exceeded expectations, underlines its strategic efforts as it moves into the next phase of growth.

Robert Half Projects Lower Q2 Revenue, Reflecting Cautious Market

Robert Half Projects Lower Q2 Revenue, Reflecting Cautious Market

Robert Half has forecasted its second-quarter revenue to range between $1.31 billion and $1.41 billion, falling short of analysts' expectations of $1.46 billion. This subdued outlook underscores a cautious market environment amid economic uncertainties. The company's first-quarter performance saw revenues drop to $1.352 billion, marking an 8% decline from the previous year. Net income took a significant hit, plummeting to $17 million, or $0.17 per share, from $64 million in Q1 2024. According to Insightia, these results reflect prolonged decision-making cycles in the market driven by apprehensions over U.S. trade and policy. Robert Half's business segments reveal mixed performance, with Contract Talent Solutions revenues declining by 13% year-over-year in March and 12% in early April. Permanent Placement saw a 10% drop in March but showed signs of recovery in April with only a 2% reduction from the prior year. The company attributes these trends to cautious hiring practices in light of ongoing economic factors.

Moelis & Company Fortifies Private Funds Advisory With Strategic Hires

Moelis & Company Fortifies Private Funds Advisory With Strategic Hires

Moelis & Company has announced the appointment of Matt Wesley as the Global Head of Private Funds Advisory as of February 2025. This strategic move highlights the firm's dedication to bolstering its offerings in the private capital sector, an area gaining significant attention for its potential market dynamism. Wesley's role includes supporting the firm's private equity clients throughout their lifecycle, aligning with the company's expansion goals. The firm reported a substantial revenue increase of 41% in the first quarter of 2025, underscoring its focus on enhancing private funds and strengthening advisory services. This strong financial performance is attributed to Moelis & Company's ongoing efforts to develop a comprehensive private capital platform. The commitment to expansion signifies the company's intention to solidify its position in the private capital advisory market. In addition to Wesley's appointment, Moelis has strategically enhanced its team with key hires. Julien Oussadon joins as a Managing Director to expand the global technology segment, while Christopher Callesano steps in as Chief Financial Officer, following Joseph Simon's departure. As reported by Insider Monkey, these appointments reflect the firm's broader strategy to improve its financial advisory capabilities across vital sectors like technology and private funds to drive sustainable growth.